[Community pharmacists' interventions to prevent and screen chronic kidney disease patients].
Chronic kidney disease (CKD) is a major concern of public health. The pharmacist is known as a health practitioner involved in prevention and therapeutic education. Our study aimed at defining the impact of community pharmacists' interventions for preventing and screening CKD. In our observational prospective study of 5 months conducted in 109 community pharmacy, we included 2 groups of patients: A (therapeutic optimization): CKD patients and B (CKD screening): population at risk. In group A, we included 354 patients, mainly women (51.2%), in stage 3 of CKD, mean age 73 years old, with hypertension alone (40.6%) or associated with diabetes (44%). About 70% of the patients had a follow up by a nephrologist and 45% of them were good adherent according to the Morisky-Green self-report. However, approximately 20% of patients did not have nephroprotective treatments in their regimen although they were on stage 3 or 4 CKD patients, and about half of them were not aware of medical situations at risk. Concerning group B, 532 patients were included. The pharmaceutical interventions screened 10% of patients with a GFR<60mL/min/1.73m2. The community pharmacists' interventions helped to optimize the therapeutic management of CKD patients and in the early screening of patients at risk. More studies are needed to extrapolate our observations to a larger population.
Institut de pharmacie, CHRU de Lille, rue Philippe-Marrache, 59000 Lille, France; EA 7365, groupe de recherche sur les formes injectables et les technologies associées (GRITA), université de Lille, 59000 Lille, France. Electronic address: stephanie.belaiche@chru-lille.fr.
Stéphanie
S
Belaiche
Institut de pharmacie, CHRU de Lille, rue Philippe-Marrache, 59000 Lille, France.
Edwige
E
Mercier
EA 4483, impact de l'environnement chimique sur la santé humaine (IMPECS), université de Lille, 59000 Lille, France.
Damien
D
Cuny
EA 7365, groupe de recherche sur les formes injectables et les technologies associées (GRITA), université de Lille, 59000 Lille, France.
Nicolas
N
Kambia
Faculté de pharmacie, université de Lille, 59000 Lille, France.
Patrick
P
Wierre
Faculté de pharmacie, université de Lille, 59000 Lille, France.
Élisabeth
É
Bertoux
Faculté de pharmacie, université de Lille, 59000 Lille, France.
Daniel
D
Mascaut
Service de néphrologie, centre hospitalier de Dunkerque, 59240 Dunkerque, France.
Raymond
R
Azar
Service de néphrologie, centre hospitalier de Boulogne-sur-Mer, 62200 Boulogne-sur-Mer, France.
Pierre
P
Bataille
Clinique du Bois, 59000 Lille, France.
Franck
F
Bourdon
Service de néphrologie, centre hospitalier de Béthune, 62131 Béthune, France.
Évelyne
É
Mac Namara
Service de néphrologie-dialyse, centre hospitalier de Valenciennes, 59322 Valenciennes, France.
Nathalie
N
Maisonneuve
Service de néphrologie, centre hospitalier de Cambrai, 59400 Cambrai, France.
Bernard
B
Painchart
Service de néphrologie-dialyse, centre hospitalier de Valenciennes, 59322 Valenciennes, France.
Laurence
L
Vrigneau
Service de néphrologie, CHRU de Lille, 59000 Lille, France; Lille inflammation research international center (LIRIC), Inserm U995, université de Lille, 59000 Lille, France.
Christian
C
Noël
Institut de pharmacie, CHRU de Lille, rue Philippe-Marrache, 59000 Lille, France; EA 7365, groupe de recherche sur les formes injectables et les technologies associées (GRITA), université de Lille, 59000 Lille, France.
Bertrand
B
Décaudin
EA 4483, impact de l'environnement chimique sur la santé humaine (IMPECS), université de Lille, 59000 Lille, France; Service de néphrologie, CHRU de Lille, 59000 Lille, France.
François
F
Glowacki
Réseau Néphronor, CHRU de Lille, 59000 Lille, France.
D000368:Aged; D005260:Female; D005602:France; D005919:Glomerular Filtration Rate; D006801:Humans; D008297:Male; D008403:Mass Screening; D010595:Pharmacists; D011446:Prospective Studies; D051436:Renal Insufficiency, Chronic / Q000175:diagnosis* / Q000517:prevention & control*
Chronic kidney disease; Entretien pharmaceutique; Maladie rénale chronique; Pharmacist intervention; Prevention; Prévention